# Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study

> **NCT04996706** · — · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 21000 (estimated)

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04996706
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-08-16
- **Primary completion:** 2031-03-31
- **Final completion:** 2031-03-31
- **Target enrollment:** 21000 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04996706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04996706, "Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04996706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*